Barrett's esophagus is a condition that can develop in patients who have chronic gastroesophageal reflux disease (GERD) or esophagitis (inflammation of the esophagus). Muscles connecting the esophagus to the stomach work to keep food and fluids in the stomach from backing into the esophagus. When this fluid does back up, reflux, commonly known as heartburn, will occur. Some patients remain asymptomatic of heartburn or chest pain even in the presence of severe reflux disease. The lack of heartburn or chest pain does not mean you do not have reflux disease.
Prolonged exposure to reflux causes esophageal cells to change into cells that resemble those of the intestine. Over time, these changes can lead to the development of precancerous cells, which is referred to as high-grade dysplasia (HGD). It is important to know that most patients with Barrett’s esophagus do not develop HGD. However, it is crucial for patients with Barrett’s esophagus to be carefully monitored, since development of HGD significantly increases the risk of developing esophageal cancer. Approximately 45 percent of patients diagnosed with HGD have undiagnosed adenocarcinoma of the esophagus.
The Division of Thoracic Surgery at Brigham and Women’s Hospital (BWH) provides specialized services for Barrett’s esophagus, such as diagnostic endoscopy, photodynamic therapy with Photofrin™, endomucosal resection therapy (EMR), and other surgical options. Our board-certified surgeons are experts in the latest minimally invasive thoracic surgical techniques, including Nissen fundoplication and trans-oral therapies.